GlassScriptPhysician profile
Wesley G Schooler
NPI 1811918741
$5,324.85
in general payments reported to CMS, 2019-2025
15 companies · $1,421 in 2025
The $1,421 reported for 2025 was more than what 77% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
See the full distribution for Plastic and Reconstructive Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $724 · 2020: $324 · 2021: $345 · 2022: $803 · 2023: $339 · 2024: $1,368 · 2025: $1,421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,477 · Long Term Medical Supply Or Device Loan: $652.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,477.28 |
| Long Term Medical Supply Or Device Loan | $651.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $2,594.03 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Mentor Cpx 2 Breast Tissue Expander, Artoura Breast Tissue Expander |
| Integra Lifesciences Corporation | $891.34 | 2022-2025 | Durasorb Monofilament Mesh, Integra, Integra Dermal Regeneration Template |
| Surgical Innovation Associates, INC. | $384.27 | 2022 | |
| Acell, INC. | $363.42 | 2019-2020 | |
| Motiva USA, LLC | $315.24 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $233.34 | 2019-2021 | |
| Endo USA, INC. | $177.52 | 2024 | Xiaflex |
| Allergan, INC. | $153.30 | 2019-2022 | |
| Depuy Synthes Sales INC. | $42.91 | 2022-2024 | Fibergraft Aeridyan Matrix, Va-Lcp |
| Sientra, INC. | $35.87 | 2019-2021 | |
| Abbvie INC. | $35.14 | 2022-2023 | Natrelle Saline-Filled Breast Implants |
| Aimmune Therapeutics, INC. | $32.31 | 2025 | Vowst |
| Boston Scientific Corporation | $26.77 | 2021 | |
| Merz North America, INC. | $24.82 | 2025 | |
| Endo Pharmaceuticals INC. | $14.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wesley Schooler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.